Clinical Trials Directory

Trials / Completed

CompletedNCT00250211

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
26 (actual)
Sponsor
AHS Cancer Control Alberta · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn whether 3 tesla (3T) MRI functional imaging will map a tumor more accurately allowing a more targeted delivery of radiation. The investigators hope to learn whether tomotherapy will be able to deliver higher radiation doses safely to the tumor while sparing the surrounding normal tissue.

Conditions

Interventions

TypeNameDescription
PROCEDUREFunctional MRI imaging and tomotherapy

Timeline

Start date
2005-03-01
Primary completion
2011-03-01
Completion
2011-04-01
First posted
2005-11-08
Last updated
2016-02-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00250211. Inclusion in this directory is not an endorsement.

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiati (NCT00250211) · Clinical Trials Directory